Baidu
map

300药品不用两票制,都是畅销药

2018-01-05 Mr.Yu 赛柏蓝

1月4日,河南科技大学第一附属医院发布《暂不执行两票制药品公示通知》,公示303个药品,暂不执行两票制。

303药品不执行两票制,大量畅销药被放行,还有辅助用药!

▍三甲医院通知,这些药品不执行两票制

1月4日,河南科技大学第一附属医院发布《暂不执行两票制药品公示通知》,公示303个药品,暂不执行两票制。


公开资料显示,该医院位于洛阳市,是一所三级甲等医院。

目录显示, 303个药品中,包括鱼精蛋白注射液、维生素K1注射液、地高辛片等临床紧缺药;也有阿奇霉素粉针剂、诺氟沙星胶囊、阿司匹林肠溶片等常用药品。

还有氧氟沙星大输液、甲硝唑大输液、冠心宁注射液。(详见附件)

▍被多地重点监控的药品,也在其中

在通知中,医院表示制定这份目录,是根据两票制文件精神——为保障临床供应,短缺药品、临床必需但使用量较小的药品,可暂不实行两票制。

不过,目录中的药品,一方面显示了医院临床的需要,可能还透露了一些微妙的东西。

如大株红景天注射液,既不属于短缺、临床使用量也不小。甚至曾被河南省人民医院在2017年12月26日发通知,列为重点监控药品。另外,内蒙、江苏、郑州等地,都将其作为辅助用药进行监控。

这份目录展示了两票制推行中的更多可能性。

▍雪舞河山,两票制全面覆盖

近几日,北方和中部降雪,2018年的第一场雪,不消多时就将大地素裹。恰似已经全国推开的两票制,覆盖河山每个角落。和纷纷冰花不同的是,两票制落地即生根,影响久远。

缩短流通环节,挤出利润,为药品采购留出议价空间,弥补医院取消药品加成后的损失。挤出来的这部分利润,让利给患者,以减缓居民医疗开支的逐年提升,最终,体现在服务国计民生的宗旨上。

两票制的逻辑基本如此。在以往的报道看,落地推开过程中,遇到的阻碍就是托管,以及界定第一票、可以三票时,口子开的过大。



版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1720780, encodeId=fe2e1e2078007, content=<a href='/topic/show?id=04b8e02985e' target=_blank style='color:#2F92EE;'>#畅销药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70298, encryptionId=04b8e02985e, topicName=畅销药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=395b32977706, createdName=tonychen32, createdTime=Wed Jun 20 05:18:00 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419586, encodeId=42f11419586be, content=<a href='/topic/show?id=447d2109ee4' target=_blank style='color:#2F92EE;'>#两票制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21097, encryptionId=447d2109ee4, topicName=两票制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1103505700, createdName=天堂的云, createdTime=Sat Jan 06 15:18:00 CST 2018, time=2018-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275562, encodeId=662f2e55629c, content=别折腾充分为人服务, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/21/9461f3b3c9f14e1d844256cdd08f2cf3.jpg, createdBy=a30f1426910, createdName=swfzhanggui, createdTime=Fri Jan 05 05:48:59 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275546, encodeId=44a52e5546bd, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Fri Jan 05 02:12:48 CST 2018, time=2018-01-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1720780, encodeId=fe2e1e2078007, content=<a href='/topic/show?id=04b8e02985e' target=_blank style='color:#2F92EE;'>#畅销药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70298, encryptionId=04b8e02985e, topicName=畅销药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=395b32977706, createdName=tonychen32, createdTime=Wed Jun 20 05:18:00 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419586, encodeId=42f11419586be, content=<a href='/topic/show?id=447d2109ee4' target=_blank style='color:#2F92EE;'>#两票制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21097, encryptionId=447d2109ee4, topicName=两票制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1103505700, createdName=天堂的云, createdTime=Sat Jan 06 15:18:00 CST 2018, time=2018-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275562, encodeId=662f2e55629c, content=别折腾充分为人服务, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/21/9461f3b3c9f14e1d844256cdd08f2cf3.jpg, createdBy=a30f1426910, createdName=swfzhanggui, createdTime=Fri Jan 05 05:48:59 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275546, encodeId=44a52e5546bd, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Fri Jan 05 02:12:48 CST 2018, time=2018-01-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1720780, encodeId=fe2e1e2078007, content=<a href='/topic/show?id=04b8e02985e' target=_blank style='color:#2F92EE;'>#畅销药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70298, encryptionId=04b8e02985e, topicName=畅销药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=395b32977706, createdName=tonychen32, createdTime=Wed Jun 20 05:18:00 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419586, encodeId=42f11419586be, content=<a href='/topic/show?id=447d2109ee4' target=_blank style='color:#2F92EE;'>#两票制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21097, encryptionId=447d2109ee4, topicName=两票制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1103505700, createdName=天堂的云, createdTime=Sat Jan 06 15:18:00 CST 2018, time=2018-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275562, encodeId=662f2e55629c, content=别折腾充分为人服务, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/21/9461f3b3c9f14e1d844256cdd08f2cf3.jpg, createdBy=a30f1426910, createdName=swfzhanggui, createdTime=Fri Jan 05 05:48:59 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275546, encodeId=44a52e5546bd, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Fri Jan 05 02:12:48 CST 2018, time=2018-01-05, status=1, ipAttribution=)]
    2018-01-05 swfzhanggui

    别折腾充分为人服务

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1720780, encodeId=fe2e1e2078007, content=<a href='/topic/show?id=04b8e02985e' target=_blank style='color:#2F92EE;'>#畅销药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70298, encryptionId=04b8e02985e, topicName=畅销药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=395b32977706, createdName=tonychen32, createdTime=Wed Jun 20 05:18:00 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419586, encodeId=42f11419586be, content=<a href='/topic/show?id=447d2109ee4' target=_blank style='color:#2F92EE;'>#两票制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21097, encryptionId=447d2109ee4, topicName=两票制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1103505700, createdName=天堂的云, createdTime=Sat Jan 06 15:18:00 CST 2018, time=2018-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275562, encodeId=662f2e55629c, content=别折腾充分为人服务, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/21/9461f3b3c9f14e1d844256cdd08f2cf3.jpg, createdBy=a30f1426910, createdName=swfzhanggui, createdTime=Fri Jan 05 05:48:59 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275546, encodeId=44a52e5546bd, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Fri Jan 05 02:12:48 CST 2018, time=2018-01-05, status=1, ipAttribution=)]
    2018-01-05 jihuaijun1112

    学习学习学习

    0

相关资讯

52药品暂停销售!

52药品暂停销售!

CFDA发布首部《中国上市药品目录集》

首部《中国上市药品目录集》发布第一批收录131个药品203个品规

CFDA重磅消息:第一批通过仿制药一致性评价品种公布!

根据《中华人民共和国药品管理法》、《国务院关于改革药品医疗器械审评审批制度的意见》(国发〔2015〕44号)、《国务院办公厅关于开展仿制药质量和疗效一致性评价的意见》(国办发〔2016〕8号)、《关于仿制药质量和疗效一致性评价工作有关事项的公告》(国家食品药品监督管理总局公告2017年第100号)的规定,经审查,现发布符合仿制药质量和疗效一致性评价要求的药品申请品种目录

总局发文:知名品种被枪毙!

近日,CFDA药品审评中心发布“一致性评价任务公示”名单,共涉及70个产品的一致性评价情况。

重磅!首批通过一致性评价品种名单出炉,华海药业是很大赢家

12月29日,CFDA官网公布了第一批通过一致性评价的品种名单,首批通过一致性评价的共有17个品规药品,涉及11个药品,7个企业。其中,华海药业是最大赢家。

5药品被踢出市场!

昨日(12月19日),上海市阳光采购网发布《关于暂停单唾液酸四己糖神经节苷脂钠注射液等药品采购资格的通知》,有5个药品被暂停采购。

Baidu
map
Baidu
map
Baidu
map